Benvenue Medical (Santa Clara, California) has received FDA 510(k) clearance for its Luna 360 interbody fusion system for treatment of symptomatic degenerative disc disease (DDD). The company said the clearance represents an important expansion of its spine product portfolio beyond the Kiva VCF treatment system into the $3.2 billion U.S. market for expandable interbody fusion devices.